维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="GUSTAFSON DL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A new cellular target for mitomycin C: a case for mitochondriat DNA显示文摘	Pritsos CA Briggs LA Gustafson DL	1997	Oncol Res1997，9，67：	1
2	A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors显示文摘	Basche M Gustafson DL Holden SN	2006	Clin Cancer Res2006，12，18：	1
3	NAD(P)H:quinone oxidoreductase1:role as a superoxide scavenger显示文摘	Siegel D Gustafson DL Dehn DL Han JY Boonchoong P Berliner LJ Ross D	2004	Mol Pharmacol2004，65，5：	1
4	Evaluation of satrapla- tin in dogs with spontaneously occurring malignant tumors显示文摘	Selting KA Wang X Gustafson DL	2011	J Vet Intern Med2011，25，4：	1
5	NAD(P)H: quinone oxidoreductase 1: role as a superoxide scavenger 显示文摘	Siegel D Gustafson DL Dehn DL	2004	Mol Pharmacol2004，65，5：	1
6	Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib ( ZD6474, Zactima ) in combination vdth radiotherapy in EGFR-positive and EGFR-nuck human head and neck tumor xenografts 显示文摘	Gustafson DL Frederick B Merz AL	2008	Cancer Chemother Pharmacol2008，61，2：	1
7	PZ-51(Ebselen)in vivo protection against adriamycin-induced mouse csrdiae and hepatic lipid peroxidation and toxicity显示文摘	Pritosos CA Sokoloff M Gustafson DL	1992	Bioehem Pharmacol1992，44，4：	1
8	A phase I biological and pharmacologic study of the heparanase in- hibitor PI-88 in patients with advanced solid tumors显示文摘	Basche M Gustafson DL Holden SN	2006	Clin Cancer Res2006，12，18：	1
9	A phase I biological and pharmacologic study of the heparanase inhibitor PI- 88 in patients with advanced solid tumors显示文摘	BASCHE M GUSTAFSON DL HOLDEN SN	2006	Clin Cancer Res2006，12，18：	1
10	A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies显示文摘	CHOW LQ GUSTAFSON DL O'BRYANT CL	2008	Cancer Chemother Pharmacol2008，63，1：	1
11	Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandet anib (ZD6474, Zactima) in combination with radiotherapy in EGFR positive and EGFR-null human head and neck tumor xenografts显示文摘	Gustafson DL Frederick B Merz AL	2008	Cancer Chemother Pharmacol2008，61，2：	1
12	A phase Ⅰ biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors显示文摘	Basche M Gustafson DL Holden SN	2006	Clin Cancer Res2006，12，18：	1
13	light-harves ring system of brown algae and diatoms: Isolation snd characterization of chlorophyll a/e and chlorophyll a/c and chlorophy a/fucoxanthin pigment-protein complexes显示文摘	Alberte RS Frideman AL Gustafson DL	1981	BiochimBiophys Acta1981，，：	1
14	Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LC-MS assay显示文摘	Gustafson DL Long ME Zirrolli JA	2003	Cancer Chemother Pharmacol2003，52，2：	1
15	A pha3e I and pharmacokinetic study of silybin-phytosome in prostate cancer patients 显示文摘	FLAIG TW GUSTAFSON DL SU LJ	2007	Invest New Drugs2007，，25：	1
16	Transcuitural Nursing Theory from a Critical Cultural Perspective显示文摘	Gustafson DL	2005	ANS Adv Nurs Sci2005，28，1：	1
17	A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors显示文摘	Basche M Gustafson DL Holden SN		0，，：	1
18	NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger显示文摘	Siegel D Gustafson DL Dehn DL	2004	Mol Pharmacol2004，65，5：	1
19	A phase I and pharmacokinetic study of silybin-pytosome in prostate cancer patients显示文摘	Flaig TW Gustafson DL Su LJ	2007	Invest New Drugs2007，25，2：	1
20	PZ-51(Ebselen) in vivo protection against adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicity显示文摘	Pritosos CR Sokoloff M Gustafson DL	1992	Biochem Pharmacol1992，44，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示